"JUVA Skin & Laser Center in Manhattan and Woodside, New York offers a variety of innovative skin and aesthetic procedures to rejuvenate skin and your overall appearance. Our physicians have often been named among the best doctors in New York, by their peers and patients, and have been featured on The Today Show, The Dr. Oz Show, The Doctors, 20/20, The View, CNN, and Good Morning America. We look forward to hearing from you and discovering how we can help improve your appearance and self-confidence. For a consultation about any of the treatments we offer, please contact JUVA Skin & Laser Center today."

During the past decade, JUVA Skin & Laser Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 6 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "JUVA Skin & Laser Center" #1 sponsor was "BTL Industries Ltd." with 4 trials, followed by "Cynosure, Inc." with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Neothetics, Inc" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "JUVA Skin & Laser Center" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "JSS Medical Research Inc." with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "JUVA Skin & Laser Center" are "Atopic Dermatitis" (6 trials), "Dermatitis, Atopic" (3 trials), "Skin Diseases" (3 trials), "Dermatitis" (2 trials) and "Eczema" (2 trials). Many other conditions were trialed in "JUVA Skin & Laser Center" in a lesser frequency.

Most popular intervention types in "JUVA Skin & Laser Center" are "Drug" (15 trials), "Device" (11 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "LIPO-202" (2 trials), "Lebrikizumab" (2 trials), "PF-04965842 100 mg" (2 trials) and "PF-04965842 200 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "JUVA Skin & Laser Center" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "JUVA Skin & Laser Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in JUVA Skin & Laser Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in JUVA Skin & Laser Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".